4 completed. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow Malathion: new trials by email Literature Review of Malathion trials Research Report on Malathion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pediatric Head Lice Study Product Comparison LICEMD, Standard Head lice product - Head Lice | Phase 2 | Completed | Hackensack Meridian Health | 97 | 2009-05-01 | 2016-07-29 |
| Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice MALG (malathion) Treatment - Pediculosis | Phase 2 / Phase 3 | Completed | Sun Pharmaceutical Industries, Inc. | 12 | 2008-09-01 | 2014-08-07 |
| Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice MALG, Ovide (malathion) lotion 0.05%, Permethrin 1% - Lice Infestations | Phase 3 | Completed | Sun Pharmaceutical Industries, Inc. | 360 | 2005-12-01 | 2013-12-23 |
| Ivermectin in the Treatment of Head Lice ivermectin, malathion - Lice Infestations | Phase 3 | Completed | Johnson & Johnson Consumer and Personal Products Worldwide | 812 | 2004-02-01 | 2011-08-22 |
Sun Pharmaceutical Industries, Inc. (2) · Hackensack Meridian Health (1) · Johnson & Johnson Consumer and Personal Products Worldwide (1)
United States (3) · France (1) · Ireland (1) · Israel (1) · United Kingdom (1)
Jeffrey Boscamp, MD (1) · Jerry Cottrell (1) · Lawrence Rosen, MD (1)